Recommendations for the Investigation, Diagnosis, and Certification of Deaths Related to Opioid Drugs

Academic Forensic Pathology

Volumn 3, Issue 1, 2013, Pages 62-76

  Davis, Gregory G ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Autopsy; Death certification; Drug abuse; Forensic pathology; Forensic toxicology; Medical toxicology; Opiate; Opioid; Postmortem; Public health; Surveillance

Indexed keywords

EID: 84880513997     PISSN: None     EISSN: 19253621     Source Type: Journal    
DOI: 10.23907/2013.010     Document Type: Review

References (62)

1. Yaksh T.L., Wallace M.S.,: Opioids, Analgesia, and Pain Management. In: Brunton L.L., Chabner B.A., Knollmann BC, eds: Goodman & Gilman's The pharmacological basis of therapeutics, 12th ed. New York: The McGraw-Hill Companies, Inc., 2011: 481–525.
2. CDC 24/7: Saving lives. Protecting people [Internet]. Atlanta: Centers for Disease Control and Prevention; c2011. Morbidity and Mortality Weekly Report (MMWR) November 4, 2011; 60(43): 1487–92. Vital Signs: Overdoses of Prescription Opioid Pain Relievers — United States, 1999–2008; 2011 Nov 4 [cited 2013 Jan 16]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm.
3. CDC. WONDER [Internet]. Atlanta: US Department of Health and Human Services, CDC; c2012. Multiple Cause of Death, 1999–2010; [cited 2013 Feb 1]. Available from: http://wonder.cdc.gov/mcd.html.
4. Warner M., Chen L.H., Makuc D.M., Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief [Internet]. 2011 Dec [cited 2013 Jan 26]. Available from: http://www.cdc.gov/nchs/data/databriefs/db81.htm.
5. Paulozzi L.J., Ibrahimova A., Rudd R.A., A comparison of Florida medical examiners’ reports and death certificates for specific drug related overdose deaths. Acad Forensic Pathol. 2012; 2(2): 190–7.
6. Davis G.G., National Association of Medical Examiners and American College of Medical Toxicology Expert Panel on Evaluating and Reporting Opioid Deaths. National Association of Medical Examiners position paper: Recommendations for the investigation, diagnosis, and certification of deaths related to opioid drugs. Acad Forensic Pathol. 2013 Mar; 3(1): 77–83.
7. Gruszecki A.C., Booth J., Davis G.G., The predictive value of history and scene investigation for toxicology results in a medical examiner population. Am J Forensic Med Pathol. 2007 Jun; 28(2): 103–6.
8. Ceelen M., Dorn T., Buster M., Post-mortem toxicological urine screening in cause of death determination. Hum Exp Toxicol. 2011 Sep; 30(9): 1165–73.
9. Hall A.J., Logan J.E., Toblin R.L., Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008 Dec 10; 300(22): 2613–20.
10. CDC 24/7: Saving lives. Protecting people [Internet]. Atlanta: Centers for Disease Control and Prevention; c2011. Morbidity and Mortality Weekly Report (MMWR) February 19, 2010; 59(6): 153–7. Adult use of prescription opioid pain medications - Utah, 2008. 2010 Feb 19 [cited 2013 Jan 26]; Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5906a1.htm.
11. Forensic Autopsy Performance Standards; 2011 revision [Internet]. Marceline (MO): National Association of Medical Examiners; 2011 Aug 11 [cited 2013 Jan 16]. 27 p. Available from: http://thename.org/index2.php?option=com_docman&task=doc_view&gid=160&Itemid=26.
12. Nashelsky M.B., Lawrence C.H., Accuracy of cause of death determination without forensic autopsy examination. Am J Forensic Med Pathol. 2003 Dec; 24(4): 313–9.
13. Moritz A.R., Classical mistakes in forensic pathology: Alan R. Moritz (American Journal of Clinical Pathology, 1956). Am J Forensic Med Pathol. 1981 Dec; 2(4): 299–308.
14. Burt R.D., Hagan H., Garfein R.S., Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18–30 years, 1994–2004. J Urban Health. 2007 May; 84(3): 436–54.
15. Nolte K.B., Taylor D.G., Richmond J.Y., Biosafety considerations for autopsy. Am J Forensic Med Pathol. 2002 Jun; 23(2): 107–22.
16. Dinis-Oliveira R.J., Carvalho F., Duarte J.A., Collection of biological samples in forensic toxicology. Toxicol Mech Methods. 2010 Sep; 20(7): 363–414.
17. U.S. National Institute of Justice, Office of Justice Programs [Internet]. Washington: the Institute; [updated 2011 Jun]. Death Investigation: A Guide for the Scene Investigator [updated 2011 Jun; cited 2013 Jan 16]. Available from: http://www.nij.gov/pubs-sum/234457.htm.
18. Practice guidelines for Florida medical examiners [Internet]. Tallahassee (FL): Florida Department of Law Enforcement; 2010 Jul 28 [cited 2013 Jan 16]. 31 p. Available from: http://www.fdle.state.f.us/Content/getdoc/916d04c4-f522-4d8a-b16b-15fe90a9b28e/Practice-Guidelines-2009-Adopted.aspx.
19. Crandall C.S., Kerrigan S., Blau R.L., The influence of site of collection on postmortem morphine concentrations in heroin overdose victims. J Forensic Sci. 2006 Mar; 51(2): 413–20.
20. Oliver W.R., Considerations for gross autopsy photography. Acad Forensic Pathol. 2011 Jul; 1(1): 52–81.
21. FDA: Protecting and promoting your health [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; c2010. FDA recall-firm press release: Actavis Inc. issues a voluntary recall of 18 lots of fentanyl transdermal system 25 mcg/h; 2010 Oct 21 [cited 2013 Jan 26]; [about 2 screens]. Available from: http://www.fda.gov/safety/recalls/ucm230498.htm.
22. Parai J.L., Milroy C., The autopsy and toxicologic deaths. Acad Forensic Pathol. 2012 Sep; 2(3): 222–7.
23. Musshoff F., Padosch S.A., Madea B., Death during patient-controlled analgesia: piritramide overdose and tissue distribution of the drug. Forensic Sci Int. 2005 Nov 25; 154(2-3): 247–51.
24. Tran M., Ciarkowski S., Wagner D., Stevenson J.G., A case study on the safety impact of implementing smart patient-controlled analgesic pumps at a tertiary care academic medical center. Jt Comm J Qual Patient Saf. 2012 Mar; 38(3): 112–9.
25. Finklea K.M., Bagalman E., Sacco L.N., Prescription drug monitoring programs. CRS Report for Congress [Internet]. Washington: Congressional Research Service; 2013 Jan 3 [cited 2013 Jan 26]. Available from: http://www.fas.org/sgp/crs/misc/R42593.pdf.
26. National Alliance for Model State Drug Laws [Internet]. Santa Fe: the Alliance; c2013. Prescription Drug Monitoring Project; [cited 2013 Jan 26] [about 5 screens]. Available from: http://www.namsdl.org/presdrug.htm.
27. Cina S.J., Collins K.A., Goldberger B.A., Toxicology: What is routine for medicolegal death investigation purposes? Acad Forensic Pathol. 2011 Jul; 1(1): 28–31.
28. Poulin C., Stein J., Butt J., Surveillance of drug overdose deaths using medical examiner data. Chronic Dis Can. 1998; 19(4): 177–82.
29. Dinis-Oliveira R.J., Santos A., Magalhães T., “Foam Cone” exuding from the mouth and nostrils following heroin overdose. Toxicol Mech Methods. 2012 Feb; 22(2): 159–60.
30. Gill J.R., Graham S.M., Ten years of “body packers” in New York City: 50 deaths. J Forensic Sci. 2002 Jul; 47(4): 843–6.
31. Linnet K., Johansen S.S., Buchard A., Dominance of pre-analytical over analytical variation for the measurement of methadone and its main metabolite in postmortem femoral blood. Forensic Sci Int. 2008 Jul 18; 179(1): 78–82.
32. Skopp G., Preanalytic aspects in postmortem toxicology. Forensic Sci Int. 2004 Jun 10; 142(2-3): 75–100.
33. Hargrove V.M., McCutcheon J.R., Comparison of drug concentrations taken from clamped and unclamped femoral vessels. J Anal Toxicol. 2008 Oct; 32(8): 621–5.
34. Pare E.M., Monforte J.R., Thibert R.J., Morphine concentrations in brain tissue from heroin-associated deaths. J Anal Toxicol. 1984 Sep-Oct; 8(5): 213–6.
35. Thompson J.G., Vanderwerf S., Seningen J., Free oxycodone concentrations in 67 postmortem cases from the Hennepin County Medical Examiner's Office. J Anal Toxicol. 2008 Oct; 32(8): 673–9.
36. Andresen H., Gullans A., Veselinovic M., Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application. J Anal Toxicol. 2012 Apr; 36(3): 182–94.
37. Cook D.S., Braithwaite R.A., Hale R.A., Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution. J Clin Pathol. 2000 Apr; 53(4): 282–5.
38. Prouty R.W., Anderson W.H., The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J Forensic Sci. 1990 Mar; 35(2): 243–70.
39. Pelissier-Alicot A.L., Gaulier J.M., Champsaur P., Marquet P., Mechanisms underlying postmortem redistribution of drugs: a review. J Anal Toxicol. 2003 Nov-Dec; 27(8): 533–44.
40. Ferner R.E., Post-mortem clinical pharmacology. Br J Clin Pharmacol. 2008 Oct; 66(4): 430–43.
41. Anderson D.T., Muto J.J., Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol. 2000 Oct; 24(7): 627–34.
42. Davis W.R., Johnson B.D., Prescription opioid use, mis use, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008 Jan 1; 92(1-3): 267–76.
43. White J.M., Irvine R.J., Mechanisms of fatal opioid overdose. Addiction. 1999 Jul; 94(7): 961–72.
44. Pleuvry B.J., Pharmacodynamic and pharmacokinetic drug interactions. Anaesth & Intensive Care Med. 2005; 6(4): 129–33.
45. Ceder G., Jones A.W., Concentration ratios of morphine to codeine in blood of impaired drivers as evidence of heroin use and not medication with codeine. Clin Chem. 2001 Nov; 47(11): 1980–4.
46. Jones A.W., Holmgren A., Concentration ratios of free-morphine to free-codeine in femoral blood in heroin-related poisoning deaths. Leg Med (Tokyo). 2011 Jul; 13(4): 171–3.
47. Cone E.J., Heit H.A., Caplan Y.H., Gourlay D., Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine. J Anal Toxicol. 2006 Jan-Feb; 30(1): 1–5.
48. Madras B.K., Kaufman M.J., Cocaine accumulation in dopamine-rich regions of the brain after i.v. administration: comparison with mazindol distribution. Synapse. 1994 Nov; 18(3): 261–75.
49. Pounder D.J., Adams E., Fuke C., Langford A.M., Site to site variability of postmortem drug concentrations in liver and lung. J Forensic Sci. 1996 Nov; 41(6): 927–32.
50. Merrick T.C., Felo J.A., Jenkins A.J., Tissue distribution of olanzapine in a postmortem case. Am J Forensic Med Pathol. 2001 Sep; 22(3): 270–4.
51. Druid H., Holmgren P., Carlsson B., Ahlner J., Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results. Forensic Sci Int. 1999 Jan 4; 99(1): 25–34.
52. Holmgren P., Carlsson B., Zackrisson A.L., Enantioselective analysis of citalopram and its metabolites in postmortem blood and genotyping for CYP2D6 and CYP2C19. J Anal Toxicol. 2004 Mar; 28(2): 94–104.
53. Johansson I., Ingelman-Sundberg M., Genetic polymorphism and toxicology – with emphasis on cytochrome P450. Toxicol Sci. 2011 Mar; 120(1): 1–13.
54. Smith H.S., Opioid metabolism. Mayo Clin Proc. 2009 Jul; 84(7): 613–24.
55. Ikediobi O.N., Shin J., Nussbaum R.L., Addressing the challenges of the clinical application of pharmacogenomic testing. Clin Pharmacol Ther. 2009 Jul; 86(1): 28–31.
56. Ferreirós N., Dresen S., Hermanns-Clausen M., Fatal and severe codeine intoxication in 3-year-old twins–interpretation of drug and metabolite concentrations. Int J Legal Med. 2009 Sep; 123(5): 387–94.
57. Manini A.F., Nelson L.S., Olsen D., Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int. 2011 Mar 20; 206(1-3): 71–6.
58. Nelson L.S., Paulozzi L.J., The toxicology Tower of Babel: why we need to agree on a lexicon in prescription opioid research. J Med Toxicol. 2012 Dec; 8(4): 331–2.
59. Cone E.J., Fant R.V., Rohay J.M., Oxycodone involvement in drug abuse deaths. II: Evidence for toxic multiple drug-drug interactions. J Anal Toxicol. 2004 Oct; 28(7): 616–24.
60. National Center for Health Statistics. Medical examiners’ and coroners’ handbook on death registration and fetal death reporting. Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2003 [cited 2013 Jan 26]. Available from: http://www.cdc.gov/nchs/data/misc/hb_me.pdf.
61. Breiding M.J., Wiersema B., Variability of undetermined manner of death classification in the US. Inj Prev. 2006 Dec; 12 Suppl 2: ii49–ii54.
62. Rosenberg M.L., Davidson L.E., Smith J.C., Operational criteria for the determination of suicide. J Forensic Sci. 1988 Nov; 33(6): 1445–56.